Our study, through the analysis of muscle biopsies of DMD and BMD patients compared with controls, was designed to provide a picture of dysregulated proteins and to identify which, beside dystrophin, are the critical molecules involved in the disruption of the well‐tuned molecular organization at the basis of muscle function. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.